• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Scand J Trauma Resusc Emerg Med . Impact of COVID-19 on mortality in out-of-hospital cardiac arrest patients with return of spontaneous circulation

tetano

Editor, Senior Moderator
Scand J Trauma Resusc Emerg Med


. 2025 May 1;33(1):75.
doi: 10.1186/s13049-025-01395-2. Impact of COVID-19 on mortality in out-of-hospital cardiac arrest patients with return of spontaneous circulation: a retrospective cohort study

Nai-Chen Shih[SUP] #[/SUP][SUP] 1 2 [/SUP], Han-Wei Yeh[SUP] #[/SUP][SUP] 3 4 5 [/SUP], Shun-Fa Yang[SUP] 1 6 [/SUP], Yu-Hsun Wang[SUP] 1 6 [/SUP], Chung-Hsien Chaou[SUP] 7 8 9 [/SUP], Chao-Bin Yeh[SUP] 10 11 12 [/SUP]



Affiliations
Abstract

Background: This study aims to compare the mortality rates of OHCA patients with and without COVID-19 infection across different follow-up periods and explores the factors may play a significant role in determining OHCA outcomes.
Methods: This study utilized data from the US Collaborative Network in TriNetX. A total of 25,271 hospitalized OHCA patients were recruited from records spanning from January 1, 2020, to December 31, 2023. Study population divided into two groups, COVID-19 positive and COVID-19 negative groups. The mortality risk of the two groups was observed based on different follow-up periods. Subgroup analyses on sex, age, antivirals use, COVID-19 virus variant epidemic period were also conducted.
Results: Our study included 2,776 patients in each group (COVID vs. non-COVID). The primary outcome was mortality at 14-day and 90-day follow-ups. COVID-19 patients had a lower 14-day mortality (HR 0.82, 95% CI: 0.76-0.88) but higher 90-day mortality (HR 1.16, 95% CI: 1.09-1.24) compared to non-COVID-19 patients. Secondary outcomes included higher mortality in COVID-19 patients under 65, and this trend persisted in those aged 65 and over. Male COVID-19 patients had elevated mortality risk. The Alpha and Delta variant period showed a higher mortality rate for COVID-19 patients than non-COVID-19 patients.
Conclusion: COVID-19 was associated with a higher risk of mortality in OHCA patients.

Keywords: COVID-19 infection; Mortality; Out-of-hospital cardiac arrest; Retrospective cohort study.

 
Back
Top Bottom